Collection description
This collection contains guidelines, forms and documents related to accessing cerliponase alfa (Brineura®) under the LSDP. Click to view the Brineura® product information on the Therapeutic Goods Administration website.
Guidelines
Forms
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Publication date:
Date last updated:
Audience:
Health sector